Scopus
EXPORT DATE: 17 June 2014

@ARTICLE{Robert2010263,
author={Robert, P.H.a  b  and Mulin, E.a  and Malléa, P.b  and David, R.a },
title={Apathy diagnosis, assessment, and treatment in Alzheimer's disease},
journal={CNS Neuroscience and Therapeutics},
year={2010},
volume={16},
number={5},
pages={263-271},
note={cited By (since 1996)17},
url={http://www.scopus.com/inward/record.url?eid=2-s2.0-77956399340&partnerID=40&md5=923d55093ad618ba1c664283ba5bb4d8},
affiliation={Centre Mémoire de Ressources et de Recherche, CHU de Nice, Université de Nice-Sophia Antipolis, Nice, France; Centre d'Innovation et d'Usage en Santé, CHU de Nice, Université de Nice-Sophia Antipolis, Nice, France},
abstract={Apathy is defined as a disorder of motivation. There is wide acknowledgement that apathy is an important behavioral syndrome in Alzheimer's disease and in various neuropsychiatric disorders. In light of recent research and the renewed interest in the correlates and impacts of apathy and in its treatments, it is important to develop criteria for apathy that will be widely accepted, have clear operational steps, and be easy to apply in clinical practice and in research settings. Meeting these needs was the focus for a task force that included members of the European Psychiatric Association, the European Alzheimer's Disease Consortium and experts from Europe, Australia and North America. © 2010 Blackwell Publishing Ltd.},
author_keywords={Alzheimer's disease;  Apathy;  Diagnostic criteria;  Neuropsychiatry;  Neurotransmitters;  Pharmacological treatment},
keywords={amantadine;  cholinesterase inhibitor;  donepezil;  dopamine;  Ginkgo biloba extract;  levodopa;  memantine;  methylphenidate;  paroxetine;  serotonin;  serotonin 1B agonist;  serotonin 2C agonist;  serotonin 3 agonist;  tianeptine;  neuroleptic agent, aged;  aging;  Alzheimer disease;  anxiety;  apathy;  Beck Depression Inventory;  brain;  clinical trial;  dementia;  depression;  disease course;  dopaminergic system;  drug efficacy;  emotion;  frontal lobe;  human;  mild cognitive impairment;  mini mental state examination;  motivation;  neurologic disease;  neuropharmacology;  neuropsychiatry;  neuropsychological test;  neurotransmission;  nonhuman;  outcomes research;  review;  serotoninergic system;  treatment outcome;  drug effect;  mood disorder;  physiology, Alzheimer Disease;  Antipsychotic Agents;  Apathy;  Humans;  Mood Disorders;  Motivation},
chemicals_cas={amantadine, 665-66-7, 768-94-5; donepezil, 120011-70-3, 120014-06-4, 142057-77-0; dopamine, 51-61-6, 62-31-7; levodopa, 59-92-7; memantine, 19982-08-2, 41100-52-1; methylphenidate, 113-45-1, 298-59-9; paroxetine, 61869-08-7; serotonin, 50-67-9; tianeptine, 66981-73-5; Antipsychotic Agents},
references={Robert, P., Verhey, F., Byrne, E.J., Grouping for behavioral and psychological symptoms in dementia: Clinical and biological aspects. Consensus paper of the European Alzheimer Disease Consortium (2005) Eur Psychiatry, 20, pp. 490-496; Starkstein, S.E., Leentjens, A.F.G., The nosological position of apathy (2008) J Neurol Neurosurg Psychiatry, 79, pp. 1088-1092; Marin, R.S., Apathy: A neuropsychiatric syndrome (1991) J Neuropsychiatry Clin Neurosci, 3, pp. 243-254; Marin, R.S., Differential diagnosis and classification of apathy (1990) Am J Psychiatry, 147, pp. 22-30; Marin, R.S., Fogel, B.S., Hawkins, J., Duffy, J., Krupp, B., Apathy: A treatable syndrome (1995) J Neuropsychiatry Clin Neurosci, 7, pp. 23-30; Starkstein, S.E., Petracca, G., Chemerinski, E., Kremer, J., Syndromic validity of apathy in Alzheimer's disease (2001) Am J Psychiatry, 158, pp. 872-877; Brown, R.G., Pluck, G., Negative symptoms: The pathology of motivation and goal-directed behavior (2000) Trends Neurosci, 23, pp. 412-417; Levy, R., Dubois, B., Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits (2006) Cereb Cortex, 16, pp. 916-928; Stuss, D.T., Van Reekum, R., Murphy, K.J., (2000) Differentiation of States and Causes of Apathy., , In. Borod, J. editor. The neuropsychology of emotion. New York. Oxford University Press; Van Reekum, R., Stuss, D.T., Ostrander, R., Apathy: Why care? (2005) J Neuropsychiatry Clin Neurosci, 17, pp. 7-19; Lopez, O.L., Becker, J.T., Sweet, R.A., Non-cognitive symptoms in mild cognitive impairment subjects (2005) Neurocase, 11, pp. 65-71; Feldman, H., Scheltens, P., Scarpini, E., Behavioral symptoms in mild cognitive impairment (2004) Neurology, 62, pp. 1199-1201; Gabryelewicz, T., Styczynska, M., Pfeffer, A., Prevalence of major and minor depression in elderly persons with mild cognitive impairment-MADRS factor analysis (2004) Int J Geriatr Psychiatry, 19, pp. 1168-1172; Sarazin, M., Berr, C., De Rotrou, J., Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study (2007) Neurology, 69, pp. 1859-1867; Robert, P., Berr, C., Volteau, M., Neuropsychological performance in mild cognitive impairment with and without apathy (2006) Dement Geriatr Cogn Dis, 21, pp. 192-197; Robert, P.H., Berr, C., Volteau, M., Importance of lack of interest in patients with mild cognitive impairment (2008) Am J Geriatr Psychiatry, 16, pp. 770-776; Vicini Chilovi, B., Conti, M., Zanetti, M., Mazzu, I., Rozzini, L., Padovani, A., Differential impact of apathy and depression in the development of dementia in mild cognitive impairment patients (2009) Dement Geriatr Cogn Disord, 27, pp. 390-398; Gonfrier, S., Andrieu, S., David, R., Course of neuropsychiatric symptoms during a four year follow-up in the REAL-FR cohort (2008) The Journal of the Alzheimer's Association, 4 (4 SUPPL. 2), p. 135; Boyle, P.A., Malloy, P.F., Treating apathy in Alzheimer's disease (2004) Dement Geriatr Cogn Disord, 17, pp. 91-99; Starkstein, S.E., Jorge, R., Mizrahi, R., Robinson, R.G., A prospective longitudinal study of apathy in Alzheimer's disease (2006) J Neurol Neurosurg Psychiatry, 77, pp. 8-11; Lechowski, L., Benoit, M., Chassagne, P., Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: The REAL longitudinal cohort study (2009) Int J Geriatri Psychiatry, 24, pp. 341-346; Drijgers, R.L., Aalten, P., Wionogrodzka, A., Verhey, F.R.J., Leentjens, A.F.G., Pharmacological treatment of apathy in neurodegenerative diseases: A systematic review (2009) Dement Geriatr Cogn Disord, 28, pp. 13-22; Lu, P.H., Edland, E., Tingus, K., Petersen, R.C., Cummings, J.L., Donepezil delays progression to AD in MCI with depressive symptoms (2009) Neurology, 72, pp. 2115-2121. , Alzheimer's Disease Cooperative Study Group; Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., An inventory for measuring depression (1961) Am J Geriatr Psychiatry, 4, pp. 561-571; Bartolini, M., Coccia, M., Luzzi, S., Provinciali, L., Ceravolo, M.G., Motivational symptoms of depression mask preclinical Alzheimer's disease in elderly subjects (2005) Dement Geriatr Cogn Disord, 19, pp. 31-36; Berger, A.K., Fratiglioni, L., Forsell, Y., Winblad, B., Bäckman, L., The occurrence of depressive symptoms in the preclinical phase of AD. A population-based study (1999) Neurology, 53, pp. 1998-2002; Robert, P.H., Onyike, C.U., Leentjens, A.F.G., Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders (2009) European Psychiaty, 24, pp. 98-104; Starkstein, S.E., Ingram, L., Garau, M.L., Mizrahi, R., On the overlap between apathy and depression in dementia (2005) J Neurol Neurosurg Psychiatry, 76, pp. 1070-1074; Benoit, M., Andrieu, S., Lechowski, L., Gillette-Guyonnet, S., Robert, P.H., Vellas, B., Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription (2008) Int J Geriatric Psychiatry, 23, pp. 409-414; Cummings, J.L., Mega, M.S., Gray, K., Rosemberg-Thompson, S., Gornbein, T., The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia (1994) Neurology, 44, pp. 2308-2314; Marin, R.S., Biedrzycki, R.C., Firinciogullari, S., Reliability and validity of the Apathy Evaluation Scale (1991) Psychiatry Res, 38, pp. 143-162; Starkstein, S.E., Mayberg, H.S., Preziosi, T.J., Andrezejewski, P., Leiguarda, R., Robinson, R.G., Reliability, validity and clinical correlates of apathy in Parkinson's disease (1992) J Neuropsychiatry Clin Neurosci, 4, pp. 134-139; Robert, P.H., Clairet, S., Benoit, M., The Apathy Inventory: Assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment (2002) Int J Geriatric Psychiatry, 17, pp. 1099-1105; Sockeel, P., Dujardin, K., Devos, D., Denève, C., Destée, A., Defebvre, L., The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: Validation in Parkinson's disease (2006) J Neurol Neurosurg Psychiatry, 77, pp. 579-584; Yesavage, J.A., Friedman, L., A follow-up study of actigraphic measures in home-residing Alzheimer's disease patients (1998) J Geriatr Psychiatry Neurol, 11, pp. 7-10; Mahlberg, R., Walther, S., Actigraphy in agitated patients with dementia: Monitoring treatment outcomes (2007) Z Gerontol Geriatr, 40, pp. 178-184; Mulin, E., David, R., Rivet, A., Apathy assessment using ambulatory actigraphy short-time recording in mild Alzheimer's disease (2009) Int Psychogeriatrics Assoc, 21, p. 116; Lavretsky, H., Neuropsychiatric symptoms in Alzheimer disease and related disorders: Why do treatments work in clinical practice but not in the randomized trials? (2008) Am J Geriatr Psychiatry, 16, pp. 523-527; Craig, A.H., Cummings, J.L., Fairbanks, L., Cerebral blood flow correlates of apathy in Alzheimer disease (1996) Arch Neuro, 53, pp. 1116-1120; Benoit, M., Dygai, I., Migneco, O., Behavioral and psychological symptoms in Alzheimer's disease (1999) Dement Geriatr Cogn Dis, 10, pp. 511-517; Migneco, O., Benoît, M., Koulibaly, P.M., Perfusion brain SPECT and statistical parametric mapping analysis indicate that apathy is a cingulate syndrome: A study in Alzheimer's disease and nondemented patients (2001) NeuroImage, 13, pp. 896-902; Benoit, M., Clairet, S., Koulibaly, M., Darcourt, J., Robert, P.H., Brain perfusion correlates of the Apathy Inventory dimensions in Alzheimer's disease (2004) Int J Geriatric Psychiary, 19, pp. 864-869; Benoit, M., Koulibaly, P.M., Migneco, O., Darcourt, J., Pringuey, D.J., Robert, P.H., Brain perfusion in Alzheimer's disease with and without apathy: A SPECT study with statistical parametric mapping analysis (2002) Psychiatry Res: Neuroimaging, 114, pp. 103-111; Holthoff, V., Baumann, B., Kalbe, E., Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression (2005) Biol Psychiatry, 57, pp. 412-421; Bruen, P.D., McGeown, W.J., Shanks, M.F., Venneri, A., Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease (2008) Brain, 131, pp. 2455-2463; Jack, C.R.J., Shiung, M.M., Weigand, S.D., Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI (2005) Neurology, 65, pp. 1227-1231; Shino, A., Watababe, T., Maeda, K., Kotani, E., Akiguchi, I., Matsuda, M., Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease (2006) Neuroimage, 33, pp. 17-26; Schultz, W., The primate basal ganglia and the voluntary control of behaviour (1999) J Consc Stud, 6, pp. 31-45; Rolls, E., (1999) The Brain and Emotion., , Oxford. Oxford University Press; Berridge, K.C., Robinson, T.E., What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? (1998) Brain Res Rev, 28, pp. 309-369; Berridge, K.C., Food reward: Brain substrates of wanting and liking (1996) Neurosci Biobehav Rev, 20, pp. 1-25; Blackburn, J.R., Phillips, A.G., Jakubovic, A., Fibiger, H.C., Dopamine and preparatory behavior (1989) Behav Neurosci, 103, pp. 15-23; Toates, F., (1986) Motivational Systems., , Cambridge. Cambridge University Press; Berridge, K.C., Comparing the emotional brains of humans and other animals (2003) Handbook of Affective Sciences., pp. 25-51. , In. Davidson, R. Goldsmith, H. Scherer, K. editors. Oxford. Oxford University Press; Berridge, K.C., Robinson, T., Parsing reward (2003) Trends Neurosci, 26, pp. 507-513; Robert, P., Darcourt, G., Koulibaly, M., Lack of initiative and interest in Alzheimer's disease. A single photon computed tomography study (2006) European Neurol, 13, pp. 729-735; David, R., Koulibaly, M.P., Benoit, M., Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases. A SPECT study with partial volume effect correction (2007) Clin Neurol Neurosurg, 110, pp. 19-24; Volkow, N.D., Logan, J., Fowler, J.S., Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism (2000) Am J Psychiatry, 157, pp. 75-80; Zhou, F.M., Wilson, C.J., Dani, J.A., Cholinergic interneuron characteristics and nicotinic properties in the striatum (2002) Neurobiology, 53, pp. 590-605; Martorana, A.F., Mori, Z., Esposito, H., Dopamine modulates cholinergic cortical excitability in Alzheimer's patients (2009) Neuropsychopharmacology, 34, pp. 2323-2328; Kapur, S., Remington, G., Serotonin-dopamine interaction and its relevance to schizophrenia (1996) Am J Psychiatry, 153, pp. 466-476; Korsgaard, S., Gerlach, J., Christensson, E., Behavioral aspects of serotonin-dopamine interaction in the monkey (1985) Eur J Pharmacol, 118, pp. 245-252; Sasaki-Adams, D.M., Kelley, A.E., Serotonin-dopamine interactions in the control of reinforcement and motor behavior (2001) Neuropsychopharmacology, 25, pp. 440-452; Yoshimoto, K., Yayama, K., Sorimachi, Y., Possibility of 5-HT3 receptor involvement in alcohol dependence: A microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption (1996) Alcohol Clin Exp Res, 20, pp. 311A-319A; De Deurwaerdere, P., Bonhomme, N., Lucas, G., Le Moal, M., Spampinato, U., Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites (1996) J Neurochem, 66, pp. 210-215; Hallbus, M., Magnusson, T., Magnusson, O., Influence of 5-HT1B/1D receptors on dopamine release in the guinea pig nucleus accumbens: A microdialysis study (1997) Neurosci Lett, 225, pp. 57-60; Walsh, S.L., Cunningham, K.A., Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine (1997) Psychopharmacology, 130, pp. 41-58; De Deurwaerdere, P., Stinus, L., Spampinato, U., Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: Role of 5-HT3 receptors (1998) J Neurosci, 18, pp. 6528-6538; Ugedo, L., Grenhoff, J., Svensson, T.H., Ritanserin, a 5-HT2 receptor antagonist, activate midbrain dopamine neurons by blocking serotonergic inhibition (1989) Psychopharmacology, 98, pp. 45-50; Kapur, S., Zipursky, R.B., Remington, G., Comparison of the 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia: Clinical and theoretical implications (1999) Am J Psychiatry, 156, pp. 286-293; Millan, M.J., Dekeyne, A., Gobert, A., Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo (1998) Neuropharmacology, 37, pp. 953-955; Park, S.B., Coull, J.T., McShane, R.H., Tryptophan depletion in normal volunteers produces selective impairments in learning and memory (1994) Neuropharmacology, 33, pp. 575-588; Rogers, R.D., Blackshaw, A.J., Middleton, H.C., Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: Implications for the monoaminergic basis of impulsive behaviour (1999) Psychopharmacology (Berl), 146, pp. 482-491; Tanaka, S.C., Doya, K., Okada, G., Ueda, K., Okamoto, Y., Yamawaki, S., Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops (2004) Nature Neurosci, 7, pp. 887-893; Smith, G.S., Kramer, E., Yilong, M.A., Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease (2009) Brain, 132, pp. 392-401; Dranovsky, A., Hen, R., Hippocampal neurogenesis: Regulation by stress and antidepressants (2006) Biol Psychiatry, 59, pp. 1136-1143; Mowla, A., Mosavinasab, M., Haghshenas, H., Haghighi, A.B., Does serotonin augmentation have any effect on cognition and activities of daily living in Alzheimer's dementia? A double-blind, placebo-controlled clinical trial (2007) J Clin Psychopharmacol, 27, pp. 484-487; Kessing, L.V., Sondergard, L., Forman, J.L., Andersen, P.K., Antidepressants and dementia (2009) J Affect Disord, 117, pp. 24-29},
correspondence_address1={Robert, P. H.; Centre Mémoire de Ressources et de Recherche, Hôpital de Cimiez, 4 av Victoria, 06000, Nice, France; email: phil.robert15@orange.fr},
issn={17555930},
doi={10.1111/j.1755-5949.2009.00132.x},
pubmed_id={20345973},
language={English},
abbrev_source_title={CNS Neurosci. Ther.},
document_type={Review},
source={Scopus},
}
